A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
about
Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cellsHost-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing AntibodiesBoth Epistasis and Diversifying Selection Drive the Structural Evolution of the Ebola Virus Glycoprotein Mucin-Like DomainHuman Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityStructural basis for Marburg virus neutralization by a cross-reactive human antibody.An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.Human Adaptation of Ebola Virus during the West African Outbreak.The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.Exacerbating and reversing lysosomal storage diseases: from yeast to humans.Ebola virus encodes a miR-155 analog to regulate importin-α5 expression.Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs
P2860
Q24562099-6AFF3F8C-ED2D-43CA-8D4E-C0CA1047AD10Q27704173-CB0BAE50-A12B-4BCF-A4C4-98041C9E8415Q28596689-FB0EEA67-020E-4EE1-B7A6-3D8DA6ADC8B4Q34463780-02417135-F27A-416F-BF13-B3A51AD6EF77Q34478514-A59EDE18-23A3-45BB-92AE-76F32D855FC3Q34898131-0250564F-C66D-4B22-80D5-11B0593C446EQ35132751-7500AB13-7299-42D9-8EE9-5D4CF8CF6885Q37252982-2BB73EB9-74AF-4EA2-B6EA-C11EEB174057Q37402042-ECEB7AFD-B126-4F01-ABD5-368384935B39Q37448307-655EC40E-9D46-4570-99E9-481A782D28E0Q37560781-9CA2B57F-73D0-4CF0-B641-F441AE1DB86BQ38880125-BC77A811-0533-401A-8053-1E9EE98EBEFBQ40038745-7183AFE2-D5C3-4E46-A7D9-7A46E811F4CDQ40109156-4691F30B-3BE1-41F6-9312-975DFEE5A0F1Q57197569-BB0691FC-A60E-4CFC-86FF-8A4C14B5BB37
P2860
A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A mutation in the Ebola virus ...... and cell-type-specific manner.
@en
A mutation in the Ebola virus ...... and cell-type-specific manner.
@nl
type
label
A mutation in the Ebola virus ...... and cell-type-specific manner.
@en
A mutation in the Ebola virus ...... and cell-type-specific manner.
@nl
prefLabel
A mutation in the Ebola virus ...... and cell-type-specific manner.
@en
A mutation in the Ebola virus ...... and cell-type-specific manner.
@nl
P2093
P2860
P50
P356
P1433
P1476
A mutation in the Ebola virus ...... and cell-type-specific manner
@en
P2093
Emily Happy Miller
Kartik Chandran
Lee Tantral
P2860
P304
P356
10.1128/JVI.01598-12
P407
P577
2013-01-09T00:00:00Z